BIOMAT Database Logo BIOMAT Database Logo

[Initial clinical response to neuroleptic treatment and serum prolactin levels in acute schizophrenic psychoses]. 1981

F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena

UI MeSH Term Description Entries
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
August 1983, Psychiatry research,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
[Pentazole-neuroleptic and neuroleptic treatment of acute schizophrenic psychoses in a catamnestic comparison].
January 1961, Psychiatria et neurologia,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
January 1981, The Journal of nervous and mental disease,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Prolactin response to neuroleptic drugs in normal and schizophrenic subjects.
January 1978, Psychopharmacology bulletin,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
April 1987, The Journal of clinical psychiatry,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Serum and cerebrospinal fluid prolactin patterns during neuroleptic treatment in schizophrenic patients.
May 1985, Pharmacopsychiatry,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
January 1983, Psychopharmacology,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.
August 1982, The Journal of nervous and mental disease,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
[Improvement criteria after neuroleptic treatment and clinical and neuroradiological factors in schizophrenic psychoses. Preliminary studies].
January 1997, Psychiatria polska,
F Fuentenebro de Diego, and J A Cabranes, and J Ramos Brieva, and M R López Jiménez, and C Santiesteban Requena
Serum prolactin levels in unmedicated schizophrenic patients.
October 1974, Archives of general psychiatry,
Copied contents to your clipboard!